- Report
- March 2025
- 200 Pages +
Global
From €4306EUR$4,799USD£3,779GBP
- Report
- April 2025
- 147 Pages
Global
From €2287EUR$2,549USD£2,008GBP
€2691EUR$2,999USD£2,362GBP
- Report
- November 2024
- 120 Pages
Global
From €5339EUR$5,950USD£4,686GBP
- Report
- August 2025
- 180 Pages
Global
From €4038EUR$4,500USD£3,544GBP
- Report
- June 2025
- 185 Pages
Global
From €4038EUR$4,500USD£3,544GBP
- Report
- October 2025
- 183 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- October 2025
- 190 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- August 2025
- 182 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- November 2025
- 273 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 604 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- September 2025
- 250 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- April 2025
- 250 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- June 2025
- 150 Pages
Global
From €2692EUR$3,000USD£2,363GBP
€3365EUR$3,750USD£2,953GBP
- Report
- April 2024
- 330 Pages
Global
From €4442EUR$4,950USD£3,898GBP
- Report
- July 2023
- 215 Pages
Global
From €3814EUR$4,250USD£3,347GBP
- Report
- May 2024
- 80 Pages
United States
From €3544EUR$3,950USD£3,111GBP
- Report
- March 2024
- 150 Pages
Global
From €5339EUR$5,950USD£4,686GBP
- Report
- February 2024
- 132 Pages
Global
From €4262EUR$4,750USD£3,741GBP

Plasmapheresis is a process used in blood banking to separate plasma from whole blood. Plasma is the liquid component of blood that contains proteins, antibodies, and other substances. Plasmapheresis is used to collect plasma for transfusion, to treat certain medical conditions, and to manufacture therapeutic proteins.
The plasmapheresis market is driven by the increasing demand for plasma-derived products, such as immunoglobulins, albumin, and clotting factors. The rising prevalence of chronic diseases, such as hemophilia and thalassemia, is also driving the market. Additionally, the growing awareness of the therapeutic benefits of plasmapheresis is expected to fuel the market growth.
Some of the major companies in the plasmapheresis market include CSL Behring, Grifols, Octapharma, Kedrion, Biotest, and China Biologic Products. Show Less Read more